The Common Vein

What is it?	A localized, nodular lesion surrounding the bronchi or bronchioles, often associated with inflammation, infection, fibrosis, or neoplastic involvement.
Characterized by	Peribronchial wall thickening, peribronchial nodularity, luminal narrowing, small airway involvement, and occasional cavitation. The nodularity arises from peribronchial inflammatory infiltration, reactive fibrosis, and epithelial hyperplasia, often accompanied by inflammatory changes in the airway walls.
Anatomically affecting	Primarily involves peribronchial lung tissue, including the bronchi, terminal bronchioles, respiratory bronchioles, and adjacent parenchyma.
Pathophysiology	Peribronchial nodules develop due to infectious, inflammatory, fibrotic, or neoplastic infiltration, leading to bronchial wall thickening, airflow obstruction, air trapping, and ventilation-perfusion mismatch.

Challenges in Identifying Peribronchial Nodules on CT

Peribronchial nodules can be difficult to resolve on CT, especially at subsegmental levels. In small airway diseases such as hypersensitivity pneumonitis (HP), respiratory bronchiolitis-interstitial lung disease (RB-ILD), infectious bronchiolitis, and other bronchiolitides, CT predominantly shows centrilobular nodules, and its resolution often does not allow for clear differentiation between peribronchial and centrilobular involvement.

At larger airway levels, peribronchial nodules may be more readily identifiable, particularly when associated with bronchial wall thickening, fibrosis, or nodular peribronchial infiltrates. However, conditions such as carcinoid tumors may blur this distinction as they can involve both endobronchial and peribronchial regions.

Importantly, while CT struggles to distinguish between certain peribronchial and centrilobular nodules, histopathology can provide clarity. Diseases such as HP, Langerhans cell histiocytosis (LCH), and granulomatous infections may appear to start peribronchially but progress to involve the bronchiolar and intra-alveolar spaces, a distinction best confirmed by tissue analysis.

Distinguishing Endobronchial vs. Peribronchial Nodules

It is almost impossible  to distinguish between endobronchial and peribronchial nodules, especially in small airways and bronchioles, due to their size and imaging limitations. Even in larger airways, differentiation may still pose challenges, such as in cases of carcinoid tumors, where lesions may have both endobronchial and peribronchial involvement.

Feature	Endobronchial Nodule	Peribronchial Nodule
Location	Inside the airway lumen	Surrounding the bronchi and bronchioles
Effect on Airways	Can cause obstruction, post-obstructive atelectasis, or pneumonia	Does not directly obstruct airways but can cause peribronchial fibrosis and wall thickening but can progress to obstruct
Imaging Findings (HRCT)	Nodules within the bronchial lumen, possible mucus plugging, air trapping distal to obstruction	Peribronchial thickening, centrilobular nodules, tree-in-bud pattern, perilymphatic distribution
Common Causes	Tumors (carcinoid, bronchogenic carcinoma), foreign body, endobronchial TB, mucus plugs	sarcoidosis, infections (fungal, mycobacterial hypersensitivity pneumonitis, granulomatosis with polyangiitis, fibrosis,

Histopathology

Feature	Description
Granulomatous inflammation	Seen in conditions like sarcoidosis and TB
Peribronchial fibrosis	Occurs in chronic inflammatory conditions
Eosinophilic infiltration	Present in eosinophilic pneumonia
Lymphocytic infiltration	Associated with hypersensitivity pneumonitis
Necrotizing granulomas	Seen in infectious or vasculitic diseases

Imaging Radiology

Modality	Findings
High-Resolution CT	Evaluates for air trapping, peribronchial thickening, centrilobular nodules, ground-glass opacities, mosaic attenuation, and small airway disease. Expiratory imaging reveals airflow obstruction.
CXR	Hilar and peribronchial opacities, reticulonodular infiltrates, hyperinflation, or volume loss.
MRI	Rarely used but can show soft tissue involvement and vascular invasion.
PET-CT	Increased FDG uptake in inflammatory and neoplastic conditions; differentiates benign vs. malignant processes.
Other Investigations	Labs: Elevated inflammatory markers (CRP, ESR), serum ACE (sarcoidosis), IgE (ABPA); PFTs: Obstructive or restrictive patterns depending on disease progression.

Differential Diagnosis

Disease	Differentiating Features
Sarcoidosis	Bilateral hilar lymphadenopathy, upper lobe fibrosis
Hypersensitivity pneumonitis	Centrilobular nodules, mosaic attenuation
Tuberculosis	Upper lobe cavitary lesions, tree-in-bud nodules
Granulomatosis with polyangiitis (Wegener’s)	Necrotizing granulomas, renal involvement
Bronchogenic carcinoma	Spiculated lung mass, mediastinal lymphadenopathy
Eosinophilic pneumonia	Peripheral ground-glass opacities, eosinophilia
IgG4-related disease	Peribronchovascular thickening, systemic organ involvement

Recommendations

Action	Purpose
Perform high-resolution CT	Better characterization of nodular and inflammatory changes
Consider bronchoscopy with biopsy	Histopathological confirmation
Treat underlying causes	Corticosteroids for immune-mediated disease, antibiotics for infections, chemotherapy for neoplasms
Monitor disease progression	Serial imaging and pulmonary function tests

Key Points and Pearls

Key Point	Clinical Significance
Peribronchial nodules	Suggest granulomatous, infectious, or inflammatory diseases
Upper lobe predominance	Common in sarcoidosis, TB, and Langerhans cell histiocytosis
Tree-in-bud nodules	Suggest infectious or aspiration-related pathology
Cavitary nodules	Consider vasculitis, infection, or malignancy
Early diagnosis	Prevents irreversible airway damage in immune-mediated and infectious conditions